+1 386-243-9402 MON – FRI : 09:00 AM – 05:00 PM

CRISPR Gene-Editing Trials Encouraging

About three years ago, I wrote about CRISPR technology, not exactly a household name. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. If you read the details about CRISPR, it might make your head hurt. It is really complex. CRISPR was discovered in 2007 when a yogurt company found a bacteria which could eliminate […]

The AI Doctor

There are 2.5 doctors for every 1,000 people in the United States. In China, there are 1.5. While artificial intelligence (AI) is being developed all around the world, China has  the most urgency behind their research and development. Computerized medical diagnosis is part of China’s grand plan to fully embrace AI by 2020. China is likely […]

Innovation and Research

Last night was the first meeting of the Western Connecticut Health Network (WCHN) Biomedical Innovation and Research Council, of which I am privileged to be a member. The meeting was held at the recently christened Rudy L. Ruggles Biomedical Research Institute in Danbury, CT. The Institute aims to advance the health of our community by […]

Gene-editing Gets Major Funding

Last year, I wrote about a team of Chinese scientists having received ethical approval to perform a clinical trial of gene-editing. The goal was to test whether gene-editing may be a potential cure for cancer. The technology used for the trial is called CRISPR/Cas9, not exactly a household name. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. Cas9 stands for […]

Notes From The Harvest Summit: The Future of Cancer

On Friday (11/10), I attended the Harvest Summit at the La Crema wine estate in the Russian River Valley of California. I promised subsequent posts to share some of what I learned. You can find the prior posts about the event by scanning through my blog at johnpatrick.com. This post from my Summit notes is about […]